Skip to main content
MedPathMedPath Home
Clinical Trials/NCT04498065
NCT04498065
Completed
N/A

MYocardial DOmmages Related to COVID-19

Centre Hospitalier Universitaire Dijon1 site in 1 country273 target enrollmentMarch 1, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCovid19Non Ischemic Myocardial InjuryMyocardial InfarctionMyocarditisTroponin Elevation

Overview

Phase
N/A
Intervention
Not specified
Conditions
Covid19
Sponsor
Centre Hospitalier Universitaire Dijon
Enrollment
273
Locations
1
Primary Endpoint
characterize the myocardial damage associated with CoV-2 SARS infection
Status
Completed
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

Myocardial injury, as assessed by elevation of cardiac troponins (Tnc), is frequent among patients with COVID-19. Although rare autopsy cases reported COVID-19 related myocardial inflammation, the origin of Tnc elevation is unknown to date. Several cardiac causes, such as myocarditis, non-ischemic myocardial injury (NIMI), or myocardial infarction (MI) may lead to Tnc kinetic. Our work will test the hypothesis that during SARS-Cov2 infection, the elevation of cardiac biomarkers could be linked to the occurrence of myocarditis.

Registry
clinicaltrials.gov
Start Date
March 1, 2020
End Date
May 31, 2022
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •COVID-19 positive patient hospitalized \< 72 h after symptoms onset with troponin assessement.

Exclusion Criteria

  • •patients hospitalized \> 72h after symptom onset

Outcomes

Primary Outcomes

characterize the myocardial damage associated with CoV-2 SARS infection

Time Frame: Through study completion, an average of 2 years

Myocardtitis diagnosis in patients COVID+ and troponin+

Study Sites (1)

Loading locations...

Similar Trials

Completed
N/A
Prediction of cardiovascular risk in chronic coronary syndrome using cardiac troponi
ISRCTN15620297Accord (United Kingdom)4,917
Recruiting
Phase 3
Corticosteroids and Myocardial Injury in CAP (COLOSSEUM TRIAL)Community-acquired Pneumonia
NCT03745664University of Roma La Sapienza122
Unknown
N/A
CMR Findings in COVID-19 Patients Presenting With Myocardial InfarctionMyocardial Infarction
NCT04628104Assiut University60
Completed
N/A
Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19COVID-19Myocardial InjuryMyocarditis
NCT04320017Groupe Hospitalier Pitie-Salpetriere500
Unknown
N/A
High-sensitivity Troponin T in Acute Myocardial Infarction After Cardiac Valvular SurgeryAcute Myocardial InfarctionDisorder; Heart, Functional, Postoperative, Cardiac SurgeryMyocardial InfarctionHeart Valve Diseases
NCT02518282University of Valladolid800